Markets:

Overview

News

Currencies

International

Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.470 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spero Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket ↗

September 07, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Spero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program ↗

September 06, 2022

Via Benzinga

Why Spero Therapeutics Shares Are Up Over 100% Today ↗

September 06, 2022

Spero Therapeutics Inc (NASDAQ: SPRO) shares are trading higher by 120% to $1.60 during Tuesday's trading session after the company received minutes from a Type A meeting with the FDA discussing steps...

Via Benzinga

Analyzing Spero Therapeutics's Short Interest ↗

September 06, 2022

Spero Therapeutics's (NASDAQ:SPRO) short percent of float has fallen 14.29% since its last report. The company recently reported that it has 410 thousand shares sold short, which...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 06, 2022

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Reminds Spero Therapeutics, Inc. (SPRO) Shareholders of Class Action Deadline and Last Few Hours to Actively Participate

July 25, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

SPRO FINAL DEADLINE TOMORROW: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 25 Deadline in Securities Class Action - SPRO

July 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)

July 22, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

July 16, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Spero Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPRO

July 01, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗

July 01, 2022

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Via Benzinga

LiveOne And 24 Stocks Moving Premarket ↗

June 29, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 92.9% to $0.2295 in pre-market trading. Allena Pharmaceuticals said it previously entered into at market issuance sales agreement with B. Riley...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 28, 2022

Gainers

Via Benzinga

InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗

June 29, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives ↗

June 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 28, 2022

On Tuesday, 87 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 28, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 28, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we go over the news for Tuesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 27, 2022

Gainers

Via Benzinga

Spero Therapeutics' Shares Plunge As FDA Issued Refusal Letter For Urinary Tract Infection Candidate ↗

June 27, 2022

The U.S.

Via Benzinga

Spero Therapeutics, Inc. Investor News: Robbins LLP is Investigating Spero Therapeutics, Inc. (SPRO) on Behalf of Shareholders

June 16, 2022

From Robbins LLP

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 14, 2022

Gainers

Via Benzinga

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)

June 09, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

NASDAQ:SPRO Investor Notice: Lawsuit Alleges Misleading Statements by Spero Therapeutics, Inc. ↗

June 09, 2022

San Diego, CA -- (SBWIRE) -- 06/09/2022 -- An investor, who purchased shares of Spero Therapeutics, Inc. (NASDAQ:SPRO), filed a lawsuit in the over alleged Securities Laws violations by Spero...

Via SBWire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spero Therapeutics, Inc. (SPRO)

June 08, 2022

From Law Offices of Howard G. Smith

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 07, 2022

Gainers

Via Benzinga

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Spero Therapeutics, Inc. (SPRO) Investors

June 07, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.